GNS (GNS) Stock Price & Analysis
GNS (GNS) fell 5.44% to USD 0.17 as of July 25, 2026 at 05:14 UTC, according to Nexqual real-time market data.
GNS last closed at USD 0.18; the session ranged USD 0.17–0.18 on volume of 2,408,220 shares. Market capitalization is $32.06M, with a 52-week range of USD 0.17–1.28 (ASE). Source: Nexqual, July 25, 2026 at 05:14 UTC.
Key Statistics (as of July 25, 2026 at 05:14 UTC)
| Price | USD 0.17 |
|---|---|
| Change | ▼ 5.44% (down) |
| Previous Close | USD 0.18 |
| Open | USD 0.18 |
| Day Range | USD 0.17 – 0.18 |
| 52-Week Range | USD 0.17 – 1.28 |
| Volume | 2,408,220 shares |
| Market Cap | $32.06M |
| Exchange | ASE |
Technical Analysis (GNS)
Nexqual's technical model rates GNS "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:14 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.68 (neutral) |
| vs SMA50 | Below (USD 0.21) |
| MACD | -0.01 (negative) |
Analyst Ratings (GNS)
Wall Street analysts rate GNS "None" based on 1 analysts, with a mean price target of USD 3.25 (range USD 3.25–3.25), per Nexqual as of July 25, 2026 at 05:14 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 3.25 |
| High Target | USD 3.25 |
| Low Target | USD 3.25 |
Earnings (GNS)
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Financials & Fundamentals (GNS)
| Total Revenue | $8.39M |
|---|---|
| Gross Margin | +32.70% |
| Operating Margin | -320.13% |
| Profit Margin | +0.00% |
| ROE | -63.61% |
| Debt / Equity | 28.6 |
| Current Ratio | 0.86 |
| Total Cash | $2.47M |
| Total Debt | $27.63M |
| Free Cash Flow | $12.47M |
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Financial Health Score (GNS)
Nexqual rates GNS's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 05:14 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $2M cash vs $28M debt |
| Cash Flow | Strong — FCF $12M, 149% margin |
| Efficiency | Critical — ROE -64%, ROA -14.1% |
Ownership (GNS)
| Insider Ownership | +14.94% |
|---|---|
| Institutional Ownership | +0.93% |
| Shares Outstanding | 191.95M |
| Float | 143.95M |
| Short % of Float | +4.91% |
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Leadership (GNS)
GNS is led by Roger James Hamilton (age 54), Founder, CEO & Director, per Nexqual as of July 25, 2026 at 05:14 UTC.
| Founder, CEO & Director | Roger James Hamilton (age 54) |
|---|---|
| CTO & Executive Director | Suraj Naik (age 39) |
| Chief Financial Officer | Gaurav Dama (age 34) |
| Chief of Staff, Chief HR Officer & Director | Eva Maria Mantziou (age 39) |
Major Backers & Investors (GNS)
Notable institutional backers of GNS include Xtx Topco Ltd, according to Nexqual as of July 25, 2026 at 05:14 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Xtx Topco Ltd | 0.14% |
Source: Nexqual, July 25, 2026 at 05:14 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COSM | Cosmos Health Inc. | USD 0.2 | ▼ 6.15% |
| HKD | AMTD Digital Inc. | USD 1.61 | ▼ 1.23% |
| MSGM | Motorsport Games Inc. | USD 4.37 | ▼ 0.46% |
| GFAI | Guardforce AI Co., Limited | USD 0.35 | ▼ 9.09% |
| NVOS | Novo Integrated Sciences, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:14 UTC. This page is informational and not investment advice.